Crocin Monotherapy in Non-Central Diabetic Macular Edema
Background: Crocin can be utilized as an anti-inflammatory component of Saffron in diabetic macular edema (DME), which is known as the most common cause of vision loss in patients with diabetes mellitus (DM). Although anti-vascular endothelial growth factor (VEGF) agents are common in non-center in...
Saved in:
Main Authors: | Mojtaba Mojtahedzadeh, Masoud Reza Manaviat, Seyed Reza Mirjalili, Adeleh Sahebnasagh, Mohammad Khan Ardani, Farahnaz Hoseinzadeh, Fatemeh Saghafi |
---|---|
Format: | Article |
Language: | English |
Published: |
Research Center for Rational Use of Drugs (RCRUD)
2024-12-01
|
Series: | Journal of Pharmaceutical Care |
Subjects: | |
Online Access: | https://jpc.tums.ac.ir/index.php/jpc/article/view/772 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ultrastructural imaging biomarkers in diabetic macular edema: A major review
by: Sagnik Sen, et al.
Published: (2025-01-01) -
Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema
by: Fatima Shafqat Khan, et al.
Published: (2023-12-01) -
Combination therapy of intravitreal ranibizumab and sub-tenon triamcinolone for treatment of resistant diabetic macular edema: a clinical study in Egypt
by: Hossam Eldin M. A. Khalil, et al.
Published: (2025-01-01) -
Outcomes of intravitreal dexamethasone implant (Ozurdex®) in patients with post-surgical macular edema – a real-world scenario
by: Elder Ohara de Oliveira Júnior, et al.
Published: (2025-01-01) -
Modern view on the treatment of diabetic macular edema
by: A.V. Shelankova, et al.
Published: (2022-07-01)